InjectiveLong
Indicators Aspects In Injective (INJ)
What Does Injective (INJ) Price Structure Show?
The Injective Protocol, after testing the $45 resistance multiple times, surpassed and reached $52.50 by mid-March 2024, from the major demand zone of $7.0, which generated more than 650% gains.
However, the INJ price deteriorated, due to instability faced by the bulls in the ascent and established a lower low by mid-April, and retested the $20 support level.
Thereon, the price tried several times to uplift again but got trapped in the $20-$30 price range for more than 100 days and then fell by piercing the $20 range's lower boundary. The price fall in Injective (INJ) formed support on the crucial demand zone at $15 by August 5th.
The horizontal of support at $15 pushed the price of INJ this week higher by nearly 40% and it has traded at $18.673, with an intraday rise of 1%.
At press time, the INJ has been obstructed near the $20 mark, and dynamic hurdles coincidingly loom, too.
The Indicators have displayed optimism, as RSI has resurged from an extremely oversold region and has pierced 14-SMA lines from below. RSI's trajectory signified that its price movement showed positivity, which could take RSI soon above the median line and headed for the overbought region.
Moreover, the MACD has shown both line convergence and a bullish cross has been anticipated next; the histogram highlights diminished bear strength and rising bull strength, where the histogram was at negative 0.006.
Therefore, INJ's near-time targets would be around $31.2, and $34, respectively.
However, failing to sustain above $15 could open the back door, and the pressure from bears could lead to lower supports at $12 and $8, respectively.
The Injective Protocol, after testing the $45 resistance multiple times, surpassed and reached $52.50 by mid-March 2024, from the major demand zone of $7.0, which generated more than 650% gains.
However, the INJ price deteriorated, due to instability faced by the bulls in the ascent and established a lower low by mid-April, and retested the $20 support level.
Thereon, the price tried several times to uplift again but got trapped in the $20-$30 price range for more than 100 days and then fell by piercing the $20 range's lower boundary. The price fall in Injective (INJ) formed support on the crucial demand zone at $15 by August 5th.
The horizontal of support at $15 pushed the price of INJ this week higher by nearly 40% and it has traded at $18.673, with an intraday rise of 1%.
At press time, the INJ has been obstructed near the $20 mark, and dynamic hurdles coincidingly loom, too.
The Indicators have displayed optimism, as RSI has resurged from an extremely oversold region and has pierced 14-SMA lines from below. RSI's trajectory signified that its price movement showed positivity, which could take RSI soon above the median line and headed for the overbought region.
Moreover, the MACD has shown both line convergence and a bullish cross has been anticipated next; the histogram highlights diminished bear strength and rising bull strength, where the histogram was at negative 0.006.
Therefore, INJ's near-time targets would be around $31.2, and $34, respectively.
However, failing to sustain above $15 could open the back door, and the pressure from bears could lead to lower supports at $12 and $8, respectively.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.